OSCR

A Disorder-Aware Computational Framework to Identify Structurally Tractable Targets in Proliferative Vitreoretinopathy.

Code ↔ Paper

4 matches between paragraphs of the paper and lines of its authors' code, computed by the harvester (lexical-v1). Click a colored paragraph or line to see its counterpart.

The 4 matches
  1. [1] § Methods › Evaluation of a Target Protein–SNAIL1 › RFdiffusion-Based Binder Design ↔ rf/examples/diffusion.ipynb, lines 475–514 · score 0.67 · initial_guess, rm aa, ProteinMPNN, soluble, folded, binder
  2. [2] § Methods › Evaluation of a Target Protein–SNAIL1 › RFdiffusion-Based Binder Design ↔ af/examples/RSO.ipynb, lines 257–320 · score 0.60 · initial guess, rm aa, Cysteine, soluble, backbone, sequences
  3. [3] § Methods › Evaluation of a Target Protein–SNAIL1 › RFdiffusion-Based Binder Design ↔ af/examples/RSO.ipynb, lines 767–801 · score 0.55 · multimer model, generated sequences, recycles, RMSD, template, pLDDT
  4. [4] § Results › RFdiffusion-Based Binder Design for SNAIL1 ↔ af/examples/RSO.ipynb, lines 121–231 · score 0.53 · designed sequence, ProteinMPNN sequence, AlphaFold, confidence, pLDDT, score

Paper

Loaded from Europe PMC by your browser, not stored by OSCR: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

Jupyter notebook · 1,098 lines · 56 KB · other · 3 matches

The registry keeps no copy of this file: the license of its repository (other) is not one it has verified to allow it. Your browser shows it from its source, with JavaScript.

It can be read at the source: af/examples/RSO.ipynb.

Overview

Authors: Mak B Djulbegovic1, Nedym Hadzijahic2, David J Taylor Gonzalez3, Michael Antonietti4, Sidra Zafar1,5, Ajay E Kuriyan1,2
  1. Wills Eye Hospital, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  2. University of Miami, Miami, Florida
  3. Department of Ophthalmology, Broward Health North, Pompano Beach, Florida
  4. Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  5. Mid Atlantic Retina at Wills Eye Hospital, Philadelphia, Pennsylvania
Institutions: Thomas Jefferson University Hospital (United States); Wills Eye Hospital (United States); University of Miami (United States); Broward Health (United States); Massachusetts Eye and Ear Infirmary (United States); Harvard University (United States); Mid Atlantic Retina (United States)
Journal: Ophthalmology science, volume 6, issue 8, article 101249
Dates: received 2 February 2026; accepted 18 May 2026; published online 25 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1016/j.xops.2026.101249 · PMID 42421755 · PMCID PMC13343151 · OpenAlex W7162299899
Open access: gold, a free copy (OpenAlex)
Status: code verified
Categories: human (organism)
Keywords: Proliferative vitreoretinopathy, Epithelial–mesenchymal transition, Intrinsic disorder, SNAIL1, Artificial intelligence
Topic: Retinal Imaging and Analysis (Radiology, Nuclear Medicine and Imaging, Medicine), according to OpenAlex
Funding: VitreoRetinal Surgery Foundation
Citations: not cited yet (Europe PMC); 62 references in the paper

Abstract

Objective: Proliferative vitreoretinopathy (PVR) remains a major cause of failure after rhegmatogenous retinal detachment repair and lacks effective pharmacologic therapies. Although epithelial–mesenchymal transition (EMT) is central to PVR pathogenesis, the structural determinants governing the tractability of EMT regulators, particularly those involving intrinsic disorder, remain poorly defined. We developed a disorder-aware, artificial intelligence–enabled computational framework to evaluate EMT-associated proteins in PVR and prioritize structurally tractable regulators for structure-based targeting.

Design: A computational, hypothesis-generating study employing an in silico screening and structural modeling pipeline.

Subjects: No human subjects or biological specimens were included. The dataset comprised 25 EMT-associated proteins implicated in PVR, curated through a narrative review of peer-reviewed literature.

Methods: Candidate proteins were evaluated using a multistage pipeline integrating intrinsic disorder profiling (Rapid Intrinsic Disorder Analysis Online), redox-sensitive disorder-to-order transition (DOT) analysis (AIUPred), and protein–protein interaction network assessment (Search Tool for the Retrieval of Interacting Genes/Proteins [STRING]). Structure-based modeling and generative binder design were then applied to the top-ranked candidate using RFdiffusion for de novo backbone generation, protein message passing neural network for sequence design, and AlphaFold2 for structural validation.

Main Outcome Measures: Primary measures were the proportion of intrinsically disordered residues, redox-sensitive disorder change, STRING network coherence within EMT-related pathways, and the structural consistency of the designed binder–target complex, assessed by root mean square deviation (RMSD) and mean per-residue confidence (predicted local distance difference test [pLDDT]).

Results: Of the 25 EMT-associated proteins screened, several exhibited intermediate intrinsic disorder profiles and measurable DOT potential. Snail Family Transcriptional Repressor 1 (SNAIL1) emerged as the highest-priority candidate, demonstrating an intermediate intrinsic disorder profile (∼35%), a pronounced redox-sensitive DOT region, and selective connectivity within EMT-related signaling networks. Functional mapping of the SNAIL1 C-terminal DOT segment identified 6 basic residues with literature-supported or motif-based regulatory significance (K187, R191, R224, K234, K253, and R264). Following sequence design and structural validation, the top-ranked binder exhibited the lowest structural deviation within the generated ensemble (RMSD 18.5 Å) and high per-residue confidence (mean pLDDT 0.84).

Conclusions: Our study introduces a disorder-informed computational framework for prioritizing structurally tractable EMT regulators in PVR. As a proof-of-concept, the pipeline nominates SNAIL1 and generates a structure-aware de novo binder targeting its C-terminal DOT region, providing a foundation for disorder-based therapeutic discovery in fibrotic retinal disease.

Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repository

Its files are read in the Code ↔ Paper reader above, with 4 matches between paragraphs and lines of code.

sokrypton/colabdesign

License: other
State: the link answers, verified on 28 September 2026
Evidence: files inventoried
Commit: e31a56fe1d9b4de25c8697f3a28b75892941cc72, 23 October 2025
Languages: Python (95), Jupyter (28), JavaScript (1)
Size: 155 files, 124 scripts
Software Heritage: not archived
Found in: the text, “RFdiffusion-Based Binder Design”
Holds: README, license file, environment (setup.py), continuous integration, 28 notebooks
Not found: CITATION.cff, tests, documentation
Tools: NumPy (77 files), JAX (71 files), Matplotlib (14 files), SciPy (10 files), pandas (7 files), Biopython (5 files), PyTorch (5 files), Plotly (2 files), Hugging Face Transformers (2 files), Keras (1 file), TensorFlow (1 file)
Availability: 1 check, the latest on 28 September 2026: the link answers
  • 28 September 2026: the link answers
126 files, not copied: shown from their source

OSCR keeps no copy of these files: the license of this repository (other) is not one it has verified to allow it. The reader above shows each one from its source, fetched by your browser at commit e31a56f, when its fingerprint is the one OSCR verified. How this works.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 124 scripts, each with its path and the digest of its content;
  • 4 matches between paragraphs of the paper and lines of the code (method lexical-v1);
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

Datasets cited

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Nedym Hadzijahic (0009-0004-1454-2705); removed Nedym Hadzijahic

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 5 keywords, 1 funder, 62 references.

Cite

This paper

Djulbegovic, M. B., Hadzijahic, N., Taylor Gonzalez, D. J., Antonietti, M., Zafar, S., & Kuriyan, A. E. (2026). A Disorder-Aware Computational Framework to Identify Structurally Tractable Targets in Proliferative Vitreoretinopathy. Ophthalmology science, 6(8), 101249. https://doi.org/10.1016/j.xops.2026.101249

BibTeX

@article{djulbegovic2026disorder,
author = {Djulbegovic, Mak B and Hadzijahic, Nedym and Taylor Gonzalez, David J and Antonietti, Michael and Zafar, Sidra and Kuriyan, Ajay E},
title = {{A Disorder-Aware Computational Framework to Identify Structurally Tractable Targets in Proliferative Vitreoretinopathy}},
journal = {Ophthalmology science},
year = {2026},
month = may,
volume = {6},
number = {8},
pages = {101249},
publisher = {Elsevier},
issn = {2666-9145},
doi = {10.1016/j.xops.2026.101249},
url = {https://doi.org/10.1016/j.xops.2026.101249},
pmid = {42421755},
pmcid = {PMC13343151}
}

RIS

TY - JOUR
AU - Djulbegovic, Mak B
AU - Hadzijahic, Nedym
AU - Taylor Gonzalez, David J
AU - Antonietti, Michael
AU - Zafar, Sidra
AU - Kuriyan, Ajay E
TI - A Disorder-Aware Computational Framework to Identify Structurally Tractable Targets in Proliferative Vitreoretinopathy
T2 - Ophthalmology science
J2 - Ophthalmol Sci
PY - 2026
DA - 2026/05/25
VL - 6
IS - 8
SP - 101249
SN - 2666-9145
PB - Elsevier
DO - 10.1016/j.xops.2026.101249
UR - https://doi.org/10.1016/j.xops.2026.101249
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.xops.2026.101249",
"type": "article-journal",
"title": "A Disorder-Aware Computational Framework to Identify Structurally Tractable Targets in Proliferative Vitreoretinopathy",
"container-title": "Ophthalmology science",
"author": [
{
"family": "Djulbegovic",
"given": "Mak B"
},
{
"family": "Hadzijahic",
"given": "Nedym"
},
{
"family": "Taylor Gonzalez",
"given": "David J"
},
{
"family": "Antonietti",
"given": "Michael"
},
{
"family": "Zafar",
"given": "Sidra"
},
{
"family": "Kuriyan",
"given": "Ajay E"
}
],
"container-title-short": "Ophthalmol Sci",
"volume": "6",
"issue": "8",
"page": "101249",
"DOI": "10.1016/j.xops.2026.101249",
"PMID": "42421755",
"PMCID": "PMC13343151",
"ISSN": "2666-9145",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.xops.2026.101249",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
25
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s42003-026-10957-8 [code]
Brain defence by the extracellular matrix protein Cochlin.
Journal: Communications biology
In common: JAX, Biopython, Hugging Face Transformers, 8 other tools
[2] doi:10.1371/journal.pone.0346575 [code]
Statistically valid explainable black-box machine learning: applications in sex classification across species using brain imaging.
Journal: PloS one
In common: JAX, Hugging Face Transformers, TensorFlow, 6 other tools
[3] doi:10.1016/j.molcel.2026.07.006 [code]
DeorphaNN: Virtual screening of GPCR peptide agonists using AlphaFold-predicted active-state complexes and deep learning embeddings.
Journal: Molecular cell
In common: JAX, Biopython, TensorFlow, 5 other tools, 1 reference
[4] doi:10.1038/s41586-026-10658-6 [code]
An AI system to help scientists write expert-level empirical software.
Journal: Nature
In common: JAX, Hugging Face Transformers, TensorFlow, 5 other tools, 1 reference
[5] doi:10.1038/s41598-026-53415-5 [code]
Computational design and immunoinformatics validation of a T cell multi-epitope vaccine targeting glioblastoma stem cells.
Journal: Scientific reports
In common: JAX, Biopython, TensorFlow, 5 other tools
[6] doi:10.1038/s41586-026-10391-0 [code]
Cell-type-targeted mitochondrial transplantation rescues cell degeneration.
Journal: Nature
In common: JAX, Biopython, TensorFlow, 5 other tools
[7] doi:10.3390/ijms27156614 [code]
Candidalysin Inhibits <i>Porphyromonas gingivalis</i> Lipoprotein-Induced IL-1β Production in BV-2 Microglia via Hydrophobic Microbial Interactions.
Journal: International journal of molecular sciences
In common: JAX, Biopython, TensorFlow, 5 other tools
[8] doi:10.1038/s41586-026-10670-w [code]
Zero-shot design of drug-binding proteins via neural iterative selection-expansion.
Journal: Nature
In common: Plotly, PyTorch, pandas, 3 other tools, 3 references
[9] doi:10.1038/s41592-026-03057-2 [code]
CREsted: modeling genomic and synthetic cell-type-specific enhancers across tissues and species.
Journal: Nature methods
In common: Biopython, Keras, TensorFlow, 5 other tools
[10] doi:10.1093/nar/gkag706 [code]
scDifformer: diffusion-based post-training for virtual cell modeling across large-scale single-cell data.
Journal: Nucleic acids research
In common: Keras, TensorFlow, PyTorch, 4 other tools, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.